Hope for a painful skin disease: psoriasis drug gets new trial
NCT ID NCT06651489
Summary
This study is testing if a medication called guselkumab, already approved for psoriasis, can help people with Hailey Hailey Disease (HHD), a rare and painful genetic skin condition. Ten participants with moderate-to-severe HHD will receive injections of the drug over 24 weeks to see if it reduces their skin symptoms and improves their quality of life. The goal is to find a more effective treatment option for this chronic disorder, which currently has no reliably effective therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAILEY HAILEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Church Street Research Unit, Yale Center for Clinical Investigation
RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.